ArticleTherapeutic advances in medical oncology2020

Fatal adverse events associated with programmed cell death protein 1 or programmed cell death-ligand 1 monotherapy in cancer.

Bin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.